Clearday Inc. (NASDAQ:CLRD) Stock Sees Selling Pressure At Higher Level

Clearday Inc. (NASDAQ: CLRD) fell 25% last week after announcing a joint venture with Invento Research Inc. The joint venture seeks to deliver the modern robotic tech to senior care settings.

Trading Data

On Friday, CLRD stock ended flat at $3.19 with 256 shares, compared to its average volume of 3.18k shares. The stock has moved within a range of $3.1900 – 3.1900 after opening trade at $3.35.

Clearday Inc. Enters Into Agreement With Invento Research Inc. and Schedules Demonstration

The two companies are working together to develop and deploy “Mitra,” a reliable companion with novel use cases that encourage patient engagement and empower healthcare workers with many conveniences. Clearday and Invento will soon launch Mitra to assist non-acute care sectors that include adoption in Clearday housing communities and home sectors with Clearday at Home to allow seniors to age-in-place.

CEO of Clearday James Walesa said that the company’s work with Invento is to create a trusted companion offering fun and engagement to seniors while also helping and protecting caregivers. Most importantly, Mitra is creating routines that allow care workers to efficiently, effectively, and safely offer enhanced care. In addition, Walesa said that Mitra offers its services entertaining, fun, and engaging. So, in the coming days, CLRD is worth keeping an eye on.

Key Quote

James Walesa CEO of Clearday stated, “Our work with Invento is developing a trusted companion that provides fun and engaging content for older Americans while also supporting, and protecting, their care givers. Mitra is developing routines that enable care workers to safely, efficiently, and effectively provide more and better care. Perhaps most importantly, Mitra provides these services in a fun, entertaining and engaging way – our residents are not intimidated by the technology, they quickly embrace and enjoy it. We believe this is the beginning of merging robotic technology and personal care and engagement to improve the quality of life for all patients.”

Technical Data

CLRD stock is trading below the 20-Day and 50-Day Moving averages of $3.44 and $3.34 respectively. Moreover, the stock is trading below the 200-Day moving average of $3.72. The stock is down 40% in the past 3-month.